Page last updated: 2024-08-26

tretazicar and Mesothelioma

tretazicar has been researched along with Mesothelioma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doshi, R; Green, NK; Kerr, DJ; McNeish, IA; Searle, PF; Young, LS1

Other Studies

1 other study(ies) available for tretazicar and Mesothelioma

ArticleYear
Immune enhancement of nitroreductase-induced cytotoxicity: studies using a bicistronic adenovirus vector.
    International journal of cancer, 2003, Mar-10, Volume: 104, Issue:1

    Topics: Adenocarcinoma; Adenoviruses, Human; Adjuvants, Immunologic; Animals; Antineoplastic Agents, Alkylating; Aziridines; Bystander Effect; Colorectal Neoplasms; Combined Modality Therapy; Cytomegalovirus; Defective Viruses; Drug Resistance, Neoplasm; Escherichia coli Proteins; Female; Genes; Genes, Synthetic; Genetic Therapy; Genetic Vectors; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunotherapy; Mesothelioma; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Nitroreductases; Prodrugs; Specific Pathogen-Free Organisms; Tumor Cells, Cultured

2003